Crotty Dylan Bram sold $145K of SYK (indirect holdings)

Stryker (NYSE:SYK) board member Ronda E. Stryker sold 350,000 shares, totaling $117.78M, according to an SEC filing. Stryker's stock rose 0.87% to $327.01. The company reported 9.42% revenue growth and a 68.27% gross margin, but has a high debt-to-equity ratio of 0.62 and overvalued P/E and P/S ratios.

STRYKER RONDA E sold 350,000 indirectly-held shares of STRYKER CORP (SYK) at an average of $336.50 ($331.74–$343.47, $117.78M total) across 20 trades over 2026-08-18 to 2026-08-19.

Wendy's (WEN) +5% on private equity interest; Equifax (EFX) +6.4% after dividend declaration; Jack Henry (JKHY) +7.4% on earnings beat; PulteGroup (PHM) +4.6% on analyst rating; Stryker (SYK) +2.7% on $100M contract.

Stryker (SYK) shares rose 2.7% after its Stryker Sales unit secured a $100M contract modification from the US Defense Logistics Agency. The stock closed at $340.05, up 2.6% from the previous close. The company reported a 9.4% year-on-year revenue increase to $6.59B in Q2 but missed organic sales growth expectations.

Wolfe Research downgraded Stryker (SYK) to Peer Perform, citing a difficult second-half outlook after a March cyber disruption and noting the June quarter did not fully catch up. Wolfe said Stryker’s guidance implies 54% of revenue in 2H. Wolfe upgraded Abbott (ABT) to Outperform with a $130 target, citing better 2027 catalysts.

Stryker (NYSE:SYK) reported Q2 results on July 30 with sales up 9.4% to $6.6B and EPS up 44.1% to $3.30. The company cited recovery from a prior cyber incident. It guided full-year organic net sales growth of 8.3% to 9.3% and adjusted EPS of $14.95 to $15.10, while the article highlights a large gap between reported and adjusted earnings.